Your browser doesn't support javascript.
loading
Follow-up Results of HCV GT2 Patients After Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC.
Kaneko, Tomohiro; Kanda, Tatsuo; Nirei, Kazushige; Matsumoto, Naoki; Yamazaki, Motomi; Shibata, Toshikatsu; Tamura, Akinori; Ogawa, Masahiro; Nakajima, Noriko; Matsuoka, Shunichi; Kuroda, Kazumichi; Komoriya, Tomoe; Yamamoto, Tatsuo; Takayama, Tadatoshi; Moriyama, Mitsuhiko.
  • Kaneko T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan kanda.tatsuo@nihon-u.ac.jp.
  • Nirei K; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Matsumoto N; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Yamazaki M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Shibata T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Tamura A; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Ogawa M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Nakajima N; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Matsuoka S; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Kuroda K; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Komoriya T; Department of Sustainable Engineering, College of Industrial Technology, Nihon University, Chiba, Japan.
  • Yamamoto T; Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan.
  • Takayama T; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
  • Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Anticancer Res ; 39(7): 3855-3862, 2019 Jul.
Article en En | MEDLINE | ID: mdl-31262913

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Hepatitis C / Sofosbuvir Tipo de estudio: Etiology_studies / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Hepatitis C / Sofosbuvir Tipo de estudio: Etiology_studies / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article